Dermatology

The AJMC® Dermatology compendium is a comprehensive resource for clinical news and expert insights for diseases related to the skin, hair, and nails.

Latest News

FDA approval. | Image Credit: aznan - stock.adobe.com
FDA Expands Dupilumab Approval as First New Biologic for Bullous Pemphigoid

June 20th 2025

Dupilumab was approved by the FDA to treat bullous pemphigoid, that demonstrated its efficacy in achieving sustained disease remission and significantly improving symptoms like itch and disease severity in adults.

Prurigo Nodularis. | Image Credit: this_baker - stock.adobe.com
Nemolizumab’s Long-Term Data Reinforce Efficacy, Tolerability in Prurigo Nodularis

June 19th 2025

Ruxolitinib cream. | Image Credit: Ladanifer - stock.adobe.com
Topical Ruxolitinib Emerges as Promising Therapy for Diverse Inflammatory Skin Conditions

June 17th 2025

Hidradenitis suppurativa. | Image Credit: Kristina Blokhin - stock.adobe.com
Pediatric Hidradenitis Suppurativa Linked to High Prevalence of Chronic Medical, Psychiatric Comorbidities

June 16th 2025

Vitiligo Awareness Month. | Image Credit: Waseem Ali Khan - stock.adobe.com
5 Things to Know for Vitiligo Awareness

June 13th 2025

Topical Therapies for the Treatment of Atopic Dermatitis: Balancing Safety, Efficacy, and Access

Develop a deeper understanding of the atopic dermatitis (AD) patient journey, explore topical therapies and treatment sequencing advancements, and gain insight regarding the payer’s perspective on AD therapies.

Atopic Dermatitis Payer Perspectives
Continuing Medical Education
View All
June 26th 2025

Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care

1.5 Credits / Dermatology, Immunology
June 26th 2025

Advancing Patient Outcomes in Hidradenitis Suppurativa: Updates and Strategies for Managed Care

1.5 Credits / Dermatology
June 26th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
June 26th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

At the doctor's office stock photo | Image Credit: iStockPhoto.com
October 13th 2023

Study Explores Dermatologic Patient Journey to Enhance Patient Care and Address Unmet Needs

Emma Andrus
A European Academy of Dermatology and Venereology study explored the pathway from dermatologic consult to diagnosis to treatment and outcomes in the health care system.
Vitiligo skin pigmentation on the hands of woman | Image Credit: Rabizo Anatolii - stock.adobe.com
October 11th 2023

Uptake of Vitiligo Treatment Low in the First Year After Diagnosis

Maggie L. Shaw
For patients who had 12 months of continuous health care coverage before and after receiving a diagnosis of vitiligo, treatment rates were at suboptimal levels.
Rash Images | © Adobe Stock
October 6th 2023

Immunotherapy Treatment Can Cause Skin-Related Toxicities

Rylan DeStefano
There are many immunotherapy-caused skin toxicities, but most can be easily managed.
Right Hand of Woman With Eczema | © iStockPhoto.com
October 6th 2023

SGM Patients With Chronic Inflammatory Skin Diseases Affected by Obstacles to Care

Justina Petrullo
Sexual and gender minority (SGM) patients with chronic inflammatory skin diseases (CSIDs) may be disproportionately influenced by cost and noncost obstacles to health care.
lisa kottschade
September 27th 2023

Nurse Practitioner Lisa Kottschade Discusses Immune-Related Adverse Events, Biomarkers

Brooke McCormick
Lisa Kottschade, RN, CNP, FAPO, a nurse practitioner at Mayo Clinic, discussed immune-related adverse events and biomarkers in relation to melanoma treatment.
a sad girl is looking down
September 24th 2023

Truncal Acne Negatively Affects Quality of Life, Self-Perception in Adolescents and Young Adults

Justina Petrullo
A survey indicated that truncal acne may negatively impact adolescents’ and young adults’ quality of life and self-perception.
dr meredith mckean
September 22nd 2023

Dr Meredith McKean Shares New Melanoma Studies, Treatment Developments

Brooke McCormick
Meredith McKean, MD, MPH, the associate director of the Sarah Cannon Research Institute's Melanoma and Skin Cancer Research Program at Tennessee Oncology, discussed new melanoma studies and treatment developments.
Medical Nurse Comforting Senior Patient Stock Photo | © iStockPhoto.com
September 19th 2023

Adalimumab Plus Surgery Delivers Better Outcomes Than Adalimumab Alone for HS

Justina Petrullo
Adalimumab in conjunction with surgery demonstrated more clinical effectiveness and improved quality of life in patients with hidradenitis suppurativa (HS) compared with outcomes in those treated with adalimumab alone.
Hidradenitis images | © Adobe Stock
September 14th 2023

HS May Cause Skin Changes That Might Lead to Peripheral Neuropathy

Justina Petrullo
Hidradenitis suppurativa (HS) may involve skin or nerve ending changes that could lead to peripheral neuropathy and changes in the transduction of specific stimuli.
acne skin stock photo | © iStockPhoto.com
September 13th 2023

No Significant Differences in Resistance Observed Against 7 Antibiotics in Those With AV

Justina Petrullo
No significant differences in resistance were observed against participants with acne vulgaris (AV) against 7 antibiotics.
skin cancer examination | Image credit:
September 8th 2023

Fecal Microbiota Different Between Patients With Melanoma, Controls

Justina Petrullo
Fecal microbiota profiles were observed to be significantly different among patients with melanoma and controls, as well as those with early-stage and late-stage melanoma.
An older man- getty images- gettyimages.com
September 6th 2023

HS in Elderly Patients Possibly Associated With Male Sex, Study Suggests

Justina Petrullo
Hidradenitis suppurativa (HS) in elderly patients is not unusual and may be associated with male sex, study suggests.
Skyscrapers
August 24th 2023

HS Leads to Substantial Decline in Work Ability, Productivity

Justina Petrullo
Hidradenitis suppurativa (HS) contributes to an extensive weakening in work ability and productivity, as well as large loss of gross value added.
Graphic of a Gene
August 21st 2023

Genetic Variants Associated With HS Linked to Risk of the Disease

Justina Petrullo
Variants associated with hidradenitis suppurativa (HS) near the SOX9 and KLF5 genes were associated with HS risk.
a medical professional touches a smartphone
August 14th 2023

Digital Health Interventions May Improve Efficacy, Efficiency of Care in Dermatology

Emma Andrus
Researchers conducted systematic mapping of relevant digital health intervention literature to determine the impact of these interventions on dermatologic care outcomes.
skin cell graphic
August 14th 2023

Presence of Sex Differences in Immunological Functioning Influences HS, Review Finds

Justina Petrullo
The presence of sex differences in immunological functioning influences hidradenitis suppurativa (HS).
silhouette of children
August 11th 2023

Study Gives Overview of Effective Treatments for Hidradenitis Suppurativa in Pediatric Patients

Heather Raglin
Studies showed the various treatments improved symptoms, but more trials need to be done.
a graphic of a gene hovers above a person's hand
August 8th 2023

Genetic Variants Associated With HS Identified

Justina Petrullo
Genetic variants associated with hidradenitis suppurativa (HS) were identified, although a causal effect is not proven.
a person touches their bare shoulder
August 3rd 2023

Hyperhidrosis Disease Burden Requires Further Understanding

Justina Petrullo
More understanding of the physical, psychological, and economic burdens of hyperhidrosis is needed.
a man holds a smartphone
August 2nd 2023

Digital App Successfully Detects Skin Cancers

Heather Raglin
Study finds that use of mHealth app could be useful in early detection of skin cancer but cautions that overdiagnosis is a possibility.
pills, syringe, and a paper that says "Kidney disease"
August 1st 2023

Patients With HS Should Be Screened for CKD

Justina Petrullo
A possible association between hidradenitis suppurativa (HS) with chronic kidney disease (CKD) suggests that patients with HS who present signs of CKD should be assessed by a nephrologist, suggests a study.
Screenshot of Haley Naik, MD, smiling
July 30th 2023

Dr Haley Naik: Improved Medical Education Can Help Reduce Diagnostic Delays of HS

Laura Joszt, MA
Some populations face longer diagnostic delays for hidradenitis suppurativa (HS), but medical education can help improve knowledge of common dermatologic diseases and reduce delays in diagnosis, said Haley Naik, MD, FAAD, associate professor of dermatology, University of California, San Francisco, School of Medicine.
mother holding baby
July 24th 2023

Survey Finds Women With HS Possess Higher Infertility Rates

Justina Petrullo
Women with hidradenitis suppurativa (HS) reported higher fertility rates compared to the general population, and most said HS symptoms did not change with fertility treatments.
Screenshot of Haley Naik, MD, smiling
July 23rd 2023

Patients With Hidradenitis Suppurativa Face Many Barriers When Accessing Care, Says Dr Haley Naik

Laura Joszt, MA
Some of the many barriers patients with hidradenitis suppurativa (HS) face include accessing knowledgeable providers, insurance coverage of treatment, and the way the health care system is set up, said Haley Naik, MD, FAAD, associate professor of dermatology, University of California, San Francisco, School of Medicine.
a patient is having their skin examined
July 22nd 2023

PAKT Tool May Be Able to Improve Outcomes for Patients with AK

Justina Petrullo
The personalizing actinic keratosis treatment (PAKT) tool may have the ability to strengthen patient-centric management of actinic keratoses (AK) in clinical practice, account for patient goals, and form reasonable treatment and care outcomes.
image of a person with itchy skin
July 21st 2023

HS Associated With Multiple Comorbidities, Underreported, Says Review

Justina Petrullo
Hidradenitis suppurativa (HS) is associated with multiple comorbidities and is underreported in developing countries, necessitating further research.
pill capsules on a table
July 17th 2023

OTC Treatment Options for Pesky Summer Rashes

Renata Block, MMS, PA-C
The American Skin Association estimated that 50 million Americans are exposed to urushiol yearly, the most common contact allergen in the United States.
Screenshot of Emma Guttman-Yassky, MD, PhD, smiling
July 16th 2023

Dr Emma Guttman-Yassky: Strong Real-World Results of Biologics, JAK Inhibitors in AD

Laura Joszt, MA
Some of the results with biologics and Janus kinase (JAK) inhibitors for atopic dermatitis have been better in practice compared with clinical trials, said Emma Guttman-Yassky, MD, PhD, FAAD, of the Icahn School of Medicine at Mount Sinai.
Book with title Hidradenitis Suppurativa on a table: © Vitalii Vodolazskyi - stock.adobe.com
July 12th 2023

Hidradenitis Suppurativa Not a Risk Factor for Severe COVID-19

Jared Kaltwasser
Patients with the chronic skin condition hidradenitis suppurativa were less likely to be hospitalized with COVID-19 vs a control group.
young woman with closed eyes touching face with acne isolated on beige: © LIGHTFIELD STUDIOS - stock.adobe.com
July 9th 2023

Acne Scarring Leaves a Lasting Psychosocial Impact

Jared Kaltwasser
More attention should be paid to prevent acne scarring and address the psychosocial consequences associated with it, authors argue.
<123456789
...
11>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo